-Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

Press/Media

Period10 May 2024

Media coverage

2

Media coverage

  • Title-Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date10/05/24
    PersonsAllan Kirk
  • Title-Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date10/05/24
    PersonsAllan Kirk